IMVT Dividend: Immunovant Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

IMVT Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	83	77	57	48	54	39
Research & Development	403	360	212	160	101	68
Operating Expenses	486	438	270	208	156	108
Other Non Operating Income (Expenses)	1	0	-1	0	0	0
Pretax Income	-462	-412	-258	-210	-156	-107
Income Tax Expense	2	0	0	0	0	0
Net Income	-464	-413	-259	-210	-156	-107
Net Income Growth	44%	59%	23%	35%	46%	62%
Shares Outstanding (Diluted)	173.64	151.57	138.1	123.08	109.68	87.76
Shares Change (YoY)	19%	10%	12%	12%	25%	103%
EPS (Diluted)	-2.67	-2.73	-1.87	-1.71	-1.43	-1.22
EPS Growth	20%	45%	10%	20%	17%	-21%
Free Cash Flow	-431	-376	-214	-188	-106	-83
Free Cash Flow Per Share	-2.48	-2.48	-1.54	-1.52	-0.96	-0.94
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-486	-438	-270	-208	-156	-108
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-486	-438	-270	-208	-156	-108
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	-0.43%	0%	0%	0%	0%	0%